Lessons Learned From Remicade Biosimilar Patent Row
On March 5, the U.S. Court of Appeals for the Federal Circuit issued a Rule 36 affirmance in Janssen Biotech Inc. v. Celltrion Healthcare Co. Ltd., resolving in Celltrion's favor a...To view the full article, register now.
Already a subscriber? Click here to view full article